Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jun 30, 2021
Q1 FY2021
As of Mar 31, 2021
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses
Restricted cash
Short-term investments
Accounts receivable, net of allowance of $1.8 million and $2.6 million, respectively
Capitalized commissions, net
Prepaid expenses and other current assets
Total current assets
Investment held in Trust Account
Property and equipment, net
Capitalized software development costs, net
Intangible assets, net
Goodwill
Operating lease right-of-use assets
Capitalized commission, non-current, net
Deferred tax assets, non-current
Other assets, non-current, net
Total assets
Current liabilities:
Accrued expenses
Advances from related party
Convertible note - related party
Current portion of long-term debt
Accounts payable
Accrued expenses and other current liabilities
Fees payable to customers
Operating lease liabilities, current
Deferred revenue
Total current liabilities
Deferred underwriting fee payable
Deferred tax liabilities, non-current
Long-term debt, net
Operating lease liabilities, non-current
Other liabilities, non-current
Total liabilities
Commitments and contingencies (Note 12)
Class A ordinary shares subject to possible redemption 27,600,000 at $10.00 per share redemption value as of September 30, 2021 and December 31, 2020
Stockholders’ equity:
Preference shares, $0.0001 par value; 1,000,000 shares authorized; none issued or outstanding
Common stock, $0.0001 par value, 1,500,000,000 shares authorized at March 31, 2023 and December 31, 2022, respectively; 491,358,090 and 488,296,792 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively
Common Class A
Common Class B
Total common stock, $0.0001 par value, 1,500,000,000 shares authorized at March 31, 2023 and December 31, 2022, respectively; 491,358,090 and 488,296,792 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Accumulated deficit
Common Class A
Common Class B
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support